Search by Drug Name or NDC
NDC 69282-0001-18 Nioxin Hair Regrowth Treatment for Women 2 g/100mL Details
Nioxin Hair Regrowth Treatment for Women 2 g/100mL
Nioxin Hair Regrowth Treatment for Women is a TOPICAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by The Wella Corporation. The primary component is MINOXIDIL.
MedlinePlus Drug Summary
Minoxidil is used with other medications to treat high blood pressure. It is in a class of medications called vasodilators. It works by relaxing the blood vessels so that blood can flow more easily through the body. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 69282-0001-18Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Minoxidil
Minoxidil is used to stimulate hair growth and to slow balding. It is most effective for people under 40 years of age whose hair loss is recent. Minoxidil has no effect on receding hairlines. It does not cure baldness; most new hair is lost within a few months after the drug is stopped.
Related Packages: 69282-0001-18Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Minoxidil Topical
Product Information
| NDC | 69282-0001 |
|---|---|
| Product ID | 69282-001_07626570-287c-56cf-e063-6294a90a4646 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Nioxin Hair Regrowth Treatment for Women |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Minoxidil |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/100mL |
| Substance Name | MINOXIDIL |
| Labeler Name | The Wella Corporation |
| Pharmaceutical Class | Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075357 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69282-0001-18 (69282000118)
| NDC Package Code | 69282-001-18 |
|---|---|
| Billing NDC | 69282000118 |
| Package | 3 BOTTLE, DROPPER in 1 CARTON (69282-001-18) / 60 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2014-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |